|
Editorial
|
|
Gene therapy and the two faces of HIV
|
1351
|
|
F Wong-Staal & GL Buchschacher Jr
|
| Full Article PDF
|
 |
|
|
Acquired diseases
|
|
Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries
|
1353
|
|
L Maillard, E Van Belle, FO Tio, A Rivard, M Kearney, D Branellec, PG Steg, JM Isner & K Walsh
|
| Abstract Full Article PDF
|
| |
|
Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle
|
1362
|
|
DR Chadwick & AML Lever
|
| Abstract Full Article PDF
|
| |
|
|
Cell-based therapy
|
|
Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR
|
1369
|
|
RA Willemsen, MEM Weijtens, C Ronteltap, Z Eshhar, JW Gratama, P Chames & RLH Bolhuis
|
| Abstract Full Article PDF
|
| |
|
|
Inherited disease
|
|
Alteration of maternal Hoxa10 expression by in vivo gene transfection affects implantation
|
1378
|
|
CN Bagot, PJ Troy & HS Taylor
|
| Abstract Full Article PDF
|
| |
|
Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient mice
|
1385
|
|
V Allamand, KM Donahue, V Straub, RL Davisson, BL Davidson & KP Campbell
|
| Abstract Full Article PDF
|
| |
|
|
Viral transfer technology
|
|
Retrovirus-mediated transduction of primary ZAP-70-deficient human T cells results in the selective growth advantage of gene-corrected cells: implications for gene therapy
|
1392
|
|
M Steinberg, L Swainson, K Schwarz, M Boyer, W Friedrich, H Yssel, N Taylor & N Noraz
|
| Abstract Full Article PDF
|
| |
|
Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity
|
1401
|
|
MJ Driesse, MC Esandi, JM Kros, CJJ Avezaat, ChJ Vecht, C Zurcher, I van der Velde, D Valerio, A Bout & PAE Sillevis Smitt
|
| Abstract Full Article PDF
|
| |
|
Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells
|
1410
|
|
SB Geutskens, MM van der Eb, AC Plomp, LE Jonges, SJ Cramer, NG Ensink, PJK Kuppen & RC Hoeben
|
| Abstract Full Article PDF
|
| |
|
Hyaluronidase enhances recombinant adeno-associated virus (rAAV)-mediated gene transfer in the rat skeletal muscle
|
1417
|
|
D Favre, Y Cherel, N Provost, V Blouin, N Ferry, P Moullier & A Salvetti
|
| Abstract Full Article PDF
|
| |
|
Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element
|
1421
|
|
MR Mautino, N Keiser & RA Morgan
|
| Abstract Full Article PDF
|
| |
|
|
Nonviral transfer technology
|
|
Liposome-mediated, nonviral gene transfer induces a systemic inflammatory response which can exacerbate pre-existing inflammation
|
1425
|
|
J Norman, W Denham, D Denham, J Yang, G Carter, A Abouhamze, CL Tannahill, SLD MacKay & LL Moldawer
|
| Abstract Full Article PDF
|
| |
|
High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery
|
1431
|
|
VFI Van Tendeloo, R Willems, P Ponsaerts, M Lenjou, G Nijs, M Vanhove, P Muylaert, P Van Cauwelaert, C Van Broeckhoven, DR Van Bockstaele & ZN Berneman
|
| Abstract Full Article PDF
|
| |
| |
| |
